ESC 365 - Comparative safety and effectiveness of vitamin K antagonist and direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter aortic valve implantation

ESC Premium Access

Comparative safety and effectiveness of vitamin K antagonist and direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter aortic valve implantation

Session: Poster Session 1 - Transcatheter aortic interventions

Topic: Pharmacotherapy

Speaker: Doctor J. Butt (Copenhagen, DK)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Jawad Haider Butt

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

1 presentation

0 follower

8 more presentations in this session

Risk adjusted comparison of in-hospital outcomes of transapical transcatheter and surgical aortic valve replacement

Speaker: Doctor P. Stachon (Freiburg, DE)

Long-term mortality in patients with paradoxical low-flow low-gradient versus normal-flow high-gradient aortic stenosis undergoing transcatheter aortic valve implantation

Speaker: Doctor L. Fusini (Milan, IT)

Pseudo-discordance mimicking low-flow low-gradient AS in TAVR patients with severe symptomatic aortic stenosis

Speaker: Doctor R. Kuperstein (Ramat Gan, IL)

Predictors of renal function improvement in patients with chronic kidney disease undergoing TAVR

Speaker: Mr M. Lemes (Sao Paulo, BR)

Inflammatory leukocyte phenotypes are associated with increased mortality after transfemoral transcatheter aortic valve implantation

Speaker: Doctor J. Hoffmann (Frankfurt, DE)

Access the full session

Poster Session 1 - Transcatheter aortic interventions

Speakers: Doctor J. Butt, Doctor P. Stachon, Doctor L. Fusini, Doctor R. Kuperstein, Mr M. Lemes...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources